CD30-CD30 Ligand Interaction in Primary Cutaneous CD30+T-Cell Lymphomas: A Clue to the Pathophysiology of Clinical Regression

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

1984 • 3,268 citations

The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells

1985 • 1,817 citations

EORTC Classification for Primary Cutaneous Lymphomas: A Proposal From the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer

1997 • 1,298 citations

Changes in size and secondary structure of the ribosomal transcription unit during vertebrate evolution

1975 • 1,188 citations

A Receptor for Tumor Necrosis Factor Defines an Unusual Family of Cellular and Viral Proteins

1990 • 977 citations

Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells

1982 • 878 citations

Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells

1994 • 844 citations

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

1997 • 780 citations

The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells

1985 • 712 citations

Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease

1992 • 654 citations

Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of Nuclear Factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2

1997 • 552 citations

Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas

1995 • 462 citations

Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign--histologically malignant

1968 • 397 citations

Preferential expression of CD30 by human CD4 ⁺ T cells producing Th2‐type cytokines

1995 • 368 citations

Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders

1993 • 342 citations

Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis.A European multicenter study of 47 patients

1993 • 318 citations

Lymphomatoid Papulosis

1968 • 318 citations

Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines

1994 • 303 citations

CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.

1995 • 252 citations

CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells.

1993 • 204 citations

Clinicopathologic and Immunologic Features Associated With Transformation of Mycosis Fungoides to Large-Cell Lymphoma

1992 • 181 citations

CD30 Contains Two Binding Sites with Different Specificities for Members of the Tumor Necrosis Factor Receptor-associated Factor Family of Signal Transducing Proteins

1996 • 171 citations

A Dominant Inhibitory Mutant of the Type II Transforming Growth Factor β Receptor in the Malignant Progression of a Cutaneous T-Cell Lymphoma

1996 • 146 citations

Most Primary Cutaneous CD30-Positive Lymphoproliferative Disorders Have a CD4-Positive Cytotoxic T-Cell Phenotype

1997 • 146 citations

An Immunocytochemical Technique Offering Increased Sensitivity and Lowered Cost with a Streptavidin-Horseradish Peroxidase Conjugate

1989 • 125 citations

CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: Evidence for a T helper 2‐mediated condition

1996 • 110 citations

CD30 expression in non‐Hodgkin's lymphoma

1990 • 110 citations

Classification of primary cutaneous T‐cell lymphomas

1994 • 87 citations

The Spectrum of Ki-1+ Cutaneous Lymphomas1

2015 • 79 citations

CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.

1996 • 76 citations

Epstein-Barr virus and CD30+ malignant lymphomas.

1993 • 69 citations

Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.

1994 • 62 citations

Malignant and reactive cells from human lymphomas frequently express Fas ligand but display a different sensitivity to Fas-mediated apoptosis

1997 • 56 citations

CD30 ligand in lymphoma patients with CD30+ tumors.

1997 • 56 citations

Fas-mediated apoptosis in tumor formation and defense.

1997 • 41 citations

Cutaneous CD30+ lymphoproliferative disorders: Expression of bcl-2 and proteins of the tumor necrosis factor receptor superfamily

1998 • 36 citations

Apoptotic and Proliferating Cells in Cutaneous Lymphoproliferative Diseases

1997 • 35 citations

CUTANEOUS LYMPHOMA: A CLINICALLY RELEVANT CLASSIFICATION

1993 • 24 citations

Cited By (0)

Loading...